Virtual reality program to improve cognitive skills in people with psychosis

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial evaluates the effectiveness of a virtual reality cognitive remediation program designed for individuals living with psychotic disorders, such as schizophrenia. Participants will undergo various assessments to confirm eligibility and will be randomly assigned to either the cognitive remediation intervention or an active control group. Over six weeks, they will engage in virtual reality exercises aimed at enhancing their thinking and social skills, while also providing feedback through questionnaires. The study will measure changes in cognitive abilities and daily functioning both immediately after the intervention and three months later.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Diagnosis of a psychosis-spectrum disorder
* Equal or between 18 to 60 years old
* Ability to read and speak English
* Be clinically stable, as defined as a total Positive And Negative Severity Symptoms score equal or between 30 - 95
* No changes to their medication dosage, starting a new medication, or stopping a medication within the past month before signing the consent form

Exclusion Criteria:

* Neurological or medical disorders that may produce cognitive impairment (including head injury with more than 1 minute of loss of consciousness)
* Intellectual disability or a score equal or below 70 on the Wechsler Abbreviated Scale of Intelligence.
* Any vision conditions that cannot be corrected with contact lenses or glasses that can fit in the virtual reality googles.
* Past history of seizures, fit, and epilepsy
* Any severe medical condition related to the eyes, ears, and balance
* History of substance use disorder within the last 3 months

Where it's running

• Royal Ottawa Mental Health Centre
  Ottawa, Ontario, Canada Recruiting

Study contacts

• Principal investigator: Synthia Guimond, PhD — Royal Ottawa Mental Health Centre
• Study coordinator: Synthia Guimond, PhD
• Email: synthia.guimond@theroyal.ca
• Phone: 613-722-6521

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Examining the effects of combined therapy for schizophrenia

  This study is testing whether combining two therapies, one for managing thoughts and another for improving cognitive skills, can help people with schizophrenia do better in their daily lives compared to using just one of the therapies.

  Recruiting at 2 sites University of Toronto · Scarborough Village, Ontario and 1 other locations · NCT05731414

• Theta-Burst Transcranial Magnetic Stimulation for Treatment-Resistant Auditory Hallucinations

  This study tests whether theta-burst transcranial magnetic stimulation can lessen persistent auditory verbal hallucinations in adults with schizophrenia-spectrum or psychotic disorders who have not responded to antipsychotic meds.

  Recruiting Ciusss de L'Est de l'Île de Montréal · Montreal, Quebec · NCT07902518

• Trying the Kiso Mind smartphone app for people with schizophrenia spectrum disorders

  This study tests whether the Kiso Mind smartphone app is acceptable, practical, and helpful for adults with schizophrenia or schizoaffective disorder alongside their usual care.

  Recruiting Charite University, Berlin, Germany · Berlin, State of Berlin · NCT07395206

• Clubhouse-based care for people with schizophrenia and related conditions

  This study tests whether the Clubhouse Model of psychosocial rehabilitation helps thinking skills and daily function more than usual community mental health care in adults with schizophrenia, schizoaffective disorder, or schizophreniform disorders.

  Recruiting Case Western Reserve University · Cleveland, Ohio · NCT07006935

• Cognitive Behavioral Therapy for Chronic Pain in Veterans with Serious Mental Illness

  This study will test whether Cognitive Behavioral Therapy for Chronic Pain (CBT-CP) helps Veterans with serious mental illness and chronic low back pain reduce pain-related interference and improve quality of life.

  Recruiting VA Office of Research and Development · Baltimore, Maryland · NCT06758414

• Using Lumateperone to improve motivation in patients with schizophrenia and psychosis

  This study is testing if Lumateperone can help people with schizophrenia or schizoaffective disorders feel more motivated and less apathetic.

  Recruiting Phase 3 Louisiana State University Health Sciences Center Shreveport · Shreveport, Louisiana · NCT06482554

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.